Obesity task force linked to WHO takes “millions” from drug firms

BMJ 2006; 332 doi: 10.1136/bmj.332.7555.1412-a (Published 15 June 2006)
Cite this as: BMJ 2006;332:1412.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ray Moynihan
  1. Byron Bay, Australia

    The International Obesity Task Force has relied heavily on funding from the drug industry for a decade, despite being widely seen as an independent think tank and having ties to the World Health Organization.

    Set up in the mid-1990s with help from grants from three drug companies, the task force aims to portray obesity as a “serious medical condition” and to promote better prevention and management strategies.

    It has a high media profile and is highly influential. A senior US member and a well respected authority on obesity, William Dietz, is currently one of the driving forces behind a …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL